Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus

Journal of Infectious Diseases

Volumn 183, Issue 9, 2001, Pages 1395-1398

  Fleeton, Marina N ^a   Chen, Margaret ^a,c   Berglund, Peter ^a   Rhodes, Gary ^d   Parker, Suezanne E ^e   Murphy, Marie ^f   Atkins, Gregory J ^f   Liljestr�m, Peter ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Vical   (United States)

^f TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN SUBCLASS; SELF REPLICATIVE RNA VACCINE; UNCLASSIFIED DRUG; VIRUS RNA; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; INFECTION RESISTANCE; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SEMLIKI FOREST ALPHAVIRUS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VACCINE PRODUCTION; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALS; ENCEPHALITIS VIRUSES, TICK-BORNE; ENCEPHALITIS, TICK-BORNE; FEMALE; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INFLUENZA A VIRUS; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUSES; RNA, VIRAL; SEMLIKI FOREST VIRUS; TH1 CELLS; TRANSFECTION; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0035341935     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/319857     Document Type: Article

References (15)

1. DNA vaccines: Immunology, application and optimization
2. Characterization of a messenger RNA polynucleotide vaccine vector
3. Gene gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization
4. In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies
5. In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model
6. A Sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expression in vivo
7. Self-replicating Semliki Forest virus RNA as recombinant vaccine
8. Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice
9. Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge
10. Protection against respiratory syncytial virus infection by DNA immunization
11. Enhancing immune responses using suicidal DNA vaccines
12. Heterologous protection against influenza by injection of DNA encoding a viral protein
13. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine
14. Recent developments in the biology of respiratory syncytial virus: Are vaccines and new treatments just round the corner?
15. Cancer therapy using a sell-replicating RNA vaccine